Navigation

Psoriasis - briakinumab (suspended) [ID65]

Briakinumab for the treatment of moderate to severe chronic plaque psoriasis (suspended)

Status: Suspended
Expected date of issue: TBC
Referral date: November 2008
Process: STA
Topic area:
  • Skin
 

NICE project team

Executive Lead: TBC
Technical Lead: TBC
Communications manager: TBC
Project manager: TBC
Assessment Group / Evidence Review Group: TBC
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC
Top


 

Consultees and commentators

To be confirmed

Top


 

Project history

Date Update
23 February 2011 The Institute has been informed by the manufacturer that it has withdrawn its application for a centralised marketing authorisation for briakinumab, as the additional new data and analyses thought to be required for a favourable opinion could not be generated within the timeframe allowed in the centralised procedure. For further information please click on the following link: http://www.nelm.nhs.uk/en/NeLM-Area/News/2011---January/17/Marketing-authorisation-application-for-briakinumab-Ozespa-withdrawn-/
 
NICE has therefore decided to suspend this appraisal on its current work programme for the time being.

As this topic has been referred to the Institute we will continue to monitor any development and will update interested parties if the situation changes.
Top


 

Key documents

This page was last updated: 28 February 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.